During the past decade, Sturdy Memorial Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 20 clinical trials were completed, i.e. on average, 2000% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sturdy Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 11 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored, "NSABP Foundation Inc" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sturdy Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "North Central Cancer Treatment Group" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "NRG Oncology" with 3 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Sturdy Memorial Hospital" are "Breast Cancer" (7 trials), "Breast Adenocarcinoma" (3 trials), "Lung Cancer" (3 trials), "Pain" (3 trials) and "Stage IIA Breast Cancer AJCC v6 and v7" (3 trials). Many other conditions were trialed in "Sturdy Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Sturdy Memorial Hospital" are "Drug" (24 trials), "Other" (17 trials), "Biological" (10 trials), "Radiation" (5 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Paclitaxel" (6 trials), "Quality-of-Life Assessment" (6 trials), "Bevacizumab" (5 trials) and "Carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Sturdy Memorial Hospital" are 16 trials for "All" genders and 13 trials for "Female" genders.

Currently, there are NaN active trials in "Sturdy Memorial Hospital". undefined are not yet recruiting, 1 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Sturdy Memorial Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sturdy Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".